JAK inhibitor safety compared to traditional systemic immunosuppressive therapies

被引：0
|
作者：
Bunick, Christopher [1 ,2 ]
Daniele, Stefano [3 ]
机构：
[1] Yale Univ, Dept Dermatol, New Haven, CT USA
[2] Yale Univ, Program Translat Biomed, New Haven, CT USA
[3] Yale Sch Med, Med Scientist Training Program, New Haven, CT USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
43852
引用
收藏
页码：AB60 / AB60
页数：1
相关论文
共 50 条
  • [1] JAK Inhibitor Safety Compared to Traditional Systemic Immunosuppressive Therapies
    Daniele, Stefano G.
    Bunick, Christopher G.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2022, 21 (12) : 1298 - 1303
  • [2] JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety
    Sarina B. Elmariah
    Jeffrey S. Smith
    Joseph F. Merola
    American Journal of Clinical Dermatology, 2022, 23 : 427 - 431
  • [3] JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety
    Elmariah, Sarina B.
    Smith, Jeffrey S.
    Merola, Joseph F.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (04) : 427 - 431
  • [4] Systemic immunosuppressive therapies for uveitis in developing countries
    Agrawal, Hitesh
    Doan, Hien
    Pham, Brandon
    Khosla, Amit
    Babu, Manohar
    McCluskey, Peter
    Nguyen, Quan Dong
    Sangwan, Virender
    Reddy, Subhakar
    Sawhney, Sujata
    Tyagi, Mudit
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (09) : 1852 - 1862
  • [5] Waiting for JAK inhibitor safety data
    Kragstrup, Tue Wenzel
    Glintborg, Bente
    Svensson, Annemarie L.
    McMaster, Christopher
    Robinson, Philip C.
    Deleuran, Bent
    Liew, David F. L.
    RMD OPEN, 2022, 8 (01):
  • [6] Combining Traditional Systemic and Biologic Therapies for Psoriasis
    Heffernan, Michael P.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2010, 29 (01) : 67 - 69
  • [7] Comparative efficacy and safety of immunosuppressive therapies for systemic sclerosis related interstitial lung disease: A Bayesian network analysis
    Zheng, Ji-Na
    Yang, Qiao-Rong
    Zhu, Gui-Qi
    Pan, Lin
    Xia, Jing-Xian
    Wang, Qiang
    MODERN RHEUMATOLOGY, 2020, 30 (04) : 687 - 695
  • [8] New JAK inhibitor safety data in 2023
    Salle, P. Vergne
    Loupret, T.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 3 - 3
  • [9] Differential dynamics of TARC during JAK-inhibitor therapy compared to biological therapies targeting type 2 inflammation
    Boesjes, Celeste M.
    Bakker, Daphne S.
    Knol, Edward F.
    de Graaf, Marlies
    van Wijk, Femke
    de Bruin-Weller, Marjolein S.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (04): : 294 - 296
  • [10] Lymphoproliferative Malignancy in Psoriatic Arthritis and the Role of Systemic Immunosuppressive Therapies
    Linh Truong
    Wong, Maida
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345